| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-28 | Mr. Michael F. MahoneyChairman, President & CEO | -386.76k | 0.00 | Other Disposition | - | 1.40M | -21.60% |
| 2026-05-20 | Mr. Edward J. LudwigLead Independent Director | 3.58k | 202.91k | 買い | 56.68 | 25.36k | 16.44% |
| 2026-05-20 | Dr. Cheryl B. PegusIndependent Director | 1.77k | 99.99k | 買い | 56.49 | 1.77k | - |
| 2026-05-19 | Mr. David Cyril HabigerIndependent Director | 4.45k | 251.10k | 買い | 55.92 - 56.95 | 13.88k | 47.20% |
| 2026-05-02 | Padraig Andrew O'Connorインサイダー | -872.00 | 49.27k | Derivative Exercise and Sale | 56.50 | 7.02k | - |
| 2026-05-02 | Padraig Andrew O'Connorインサイダー | 930.00 | 0.00 | Derivative Exercise and Retained Stock | - | 7.02k | 15.26% |
| 2026-05-02 | Mr. Arthur Crosswell ButcherExec. VP and Group President of MedSurg & Asia Pacific | -1.01k | 56.90k | Derivative Exercise and Sale | 56.50 | 77.12k | - |
| 2026-05-02 | Mr. Arthur Crosswell ButcherExec. VP and Group President of MedSurg & Asia Pacific | 1.10k | 0.00 | Derivative Exercise and Retained Stock | - | 77.12k | 1.44% |
| 2026-03-01 | Ms. Emily M. WoodworthSenior VP, Global Controller & CAO | 466.00 | 0.00 | Derivative Exercise and Retained Stock | - | 2.86k | 19.47% |
| 2026-03-01 | Ms. Emily M. WoodworthSenior VP, Global Controller & CAO | -372.00 | 28.59k | Derivative Exercise and Sale | 76.85 | 2.86k | - |
| 2026-02-19 | Mr. Arthur Crosswell ButcherExec. VP and Group President of MedSurg & Asia Pacific | 6.85k | 519.03k | Acquisition Under Employee Benefit Plan | 75.76 | 76.00k | 9.91% |
| 2026-02-14 | Mr. Joseph M. FitzgeraldExec. VP & Group President of Cardiovascular | 8.32k | 0.00 | Derivative Exercise and Retained Stock | - | 219.14k | 3.95% |
| 2026-02-13 | Mr. Joseph M. FitzgeraldExec. VP & Group President of Cardiovascular | -2.80k | 209.02k | Derivative Exercise and Sale | 74.73 | 219.14k | - |
| 2026-02-13 | Mr. Joseph M. FitzgeraldExec. VP & Group President of Cardiovascular | -34.10k | 2.55M | Sale to Issuer | 74.73 | 219.14k | -13.47% |
| 2026-02-14 | Mr. Michael F. MahoneyChairman, President & CEO | 32.79k | 0.00 | Derivative Exercise and Retained Stock | - | 1.79M | 1.87% |
| 2026-02-13 | Mr. Michael F. MahoneyChairman, President & CEO | -8.83k | 660.02k | Derivative Exercise and Sale | 74.73 | 1.79M | - |
| 2026-02-13 | Mr. Michael F. MahoneyChairman, President & CEO | -139.12k | 10.40M | Sale to Issuer | 74.73 | 1.79M | -7.21% |
| 2026-02-13 | Mr. Jonathan R. MonsonExec. VP & CFO | 2.12k | 0.00 | Derivative Exercise and Retained Stock | - | 37.99k | 5.90% |
| 2026-02-13 | Mr. Jonathan R. MonsonExec. VP & CFO | -1.70k | 126.89k | Derivative Exercise and Sale | 74.73 | 37.99k | - |
| 2026-02-13 | Miriam O'sullivanインサイダー | 1.88k | 0.00 | Derivative Exercise and Retained Stock | - | 19.03k | 10.97% |
| 2026-02-13 | Miriam O'sullivanインサイダー | -820.00 | 61.28k | Derivative Exercise and Sale | 74.73 | 19.03k | - |
| 2026-02-13 | Padraig Andrew O'Connorインサイダー | 1.61k | 0.00 | Derivative Exercise and Retained Stock | - | 6.09k | 35.84% |
| 2026-02-13 | Padraig Andrew O'Connorインサイダー | -987.00 | 73.76k | Derivative Exercise and Sale | 74.73 | 6.09k | - |
| 2026-02-13 | Ms. Emily M. WoodworthSenior VP, Global Controller & CAO | 1.44k | 0.00 | Derivative Exercise and Retained Stock | - | 2.39k | 151.63% |
| 2026-02-13 | Ms. Emily M. WoodworthSenior VP, Global Controller & CAO | -1.27k | 94.83k | Derivative Exercise and Sale | 74.73 | 2.39k | - |
| 2026-02-14 | Mr. Vance R. BrownEVP, General Counsel & Corporate Secretary | 3.69k | 0.00 | Derivative Exercise and Retained Stock | - | 54.24k | 7.30% |
| 2026-02-13 | Mr. Vance R. BrownEVP, General Counsel & Corporate Secretary | -1.12k | 83.55k | Derivative Exercise and Sale | 74.73 | 54.24k | - |
| 2026-02-13 | Mr. Vance R. BrownEVP, General Counsel & Corporate Secretary | -13.46k | 1.01M | Sale to Issuer | 74.73 | 54.24k | -19.88% |
| 2026-02-14 | Mr. Arthur Crosswell ButcherExec. VP and Group President of MedSurg & Asia Pacific | 5.72k | 0.00 | Derivative Exercise and Retained Stock | - | 69.15k | 9.02% |
| 2026-02-13 | Mr. Arthur Crosswell ButcherExec. VP and Group President of MedSurg & Asia Pacific | -2.24k | 167.17k | Derivative Exercise and Sale | 74.73 | 69.15k | - |
| 2026-02-13 | Mr. Arthur Crosswell ButcherExec. VP and Group President of MedSurg & Asia Pacific | -25.68k | 1.92M | Sale to Issuer | 74.73 | 69.15k | -27.08% |
| 2026-02-12 | Miriam O'sullivanインサイダー | 623.00 | 0.00 | Derivative Exercise and Retained Stock | - | 17.15k | 3.77% |
| 2026-02-12 | Miriam O'sullivanインサイダー | -338.00 | 25.05k | Derivative Exercise and Sale | 74.12 | 17.15k | - |
| 2026-02-12 | Padraig Andrew O'Connorインサイダー | 601.00 | 0.00 | Derivative Exercise and Retained Stock | - | 4.49k | 15.47% |
| 2026-02-12 | Padraig Andrew O'Connorインサイダー | -457.00 | 33.87k | Derivative Exercise and Sale | 74.12 | 4.49k | - |
| 2026-02-12 | Ms. Emily M. WoodworthSenior VP, Global Controller & CAO | 239.00 | 0.00 | Derivative Exercise and Retained Stock | - | 951.00 | 33.57% |
| 2026-02-12 | Ms. Emily M. WoodworthSenior VP, Global Controller & CAO | -242.00 | 17.94k | Derivative Exercise and Sale | 74.12 | 951.00 | - |
| 2026-02-12 | Mr. Jonathan R. MonsonExec. VP & CFO | 581.00 | 0.00 | Derivative Exercise and Retained Stock | - | 35.87k | 1.65% |
| 2026-02-12 | Mr. Jonathan R. MonsonExec. VP & CFO | -573.00 | 42.47k | Derivative Exercise and Sale | 74.12 | 35.87k | - |
| 2026-02-12 | Mr. Michael F. MahoneyChairman, President & CEO | 7.08k | 0.00 | Derivative Exercise and Retained Stock | - | 1.63M | 0.44% |
| 2026-02-12 | Mr. Michael F. MahoneyChairman, President & CEO | -6.63k | 491.12k | Derivative Exercise and Sale | 74.12 | 1.63M | - |
| 2026-02-12 | Mr. Joseph M. FitzgeraldExec. VP & Group President of Cardiovascular | 1.85k | 0.00 | Derivative Exercise and Retained Stock | - | 175.13k | 1.07% |
| 2026-02-12 | Mr. Joseph M. FitzgeraldExec. VP & Group President of Cardiovascular | -1.61k | 119.48k | Derivative Exercise and Sale | 74.12 | 175.13k | - |
| 2026-02-12 | Mr. Vance R. BrownEVP, General Counsel & Corporate Secretary | 954.00 | 0.00 | Derivative Exercise and Retained Stock | - | 34.41k | 2.85% |
| 2026-02-12 | Mr. Vance R. BrownEVP, General Counsel & Corporate Secretary | -488.00 | 36.17k | Derivative Exercise and Sale | 74.12 | 34.41k | - |
| 2026-02-12 | Mr. Arthur Crosswell ButcherExec. VP and Group President of MedSurg & Asia Pacific | 1.39k | 0.00 | Derivative Exercise and Retained Stock | - | 38.34k | 3.76% |
| 2026-02-12 | Mr. Arthur Crosswell ButcherExec. VP and Group President of MedSurg & Asia Pacific | -1.30k | 96.50k | Derivative Exercise and Sale | 74.12 | 38.34k | - |
| 2026-02-02 | Mr. Michael F. MahoneyChairman, President & CEO | -95.75k | 6.48M | Derivative Exercise and Sale | 24.55 - 94.06 | 1.63M | - |
| 2026-02-02 | Mr. Michael F. MahoneyChairman, President & CEO | -65.15k | 6.09M | Automatic Disposition | 93.49 | 1.63M | -3.85% |
| 2025-12-01 | Mr. Arthur Crosswell ButcherExec. VP and Group President of MedSurg & Asia Pacific | -17.31k | 1.33M | Derivative Exercise and Sale | 17.26 - 101.55 | 36.95k | - |
| 2025-11-28 | Miriam O'sullivanインサイダー | -260.00 | 0.00 | Other Disposition | - | 16.53k | -1.55% |
| 2025-11-12 | Mr. Joseph M. FitzgeraldExec. VP & Group President of Cardiovascular | -10.30k | 0.00 | Other Disposition | - | 173.28k | -5.61% |
| 2025-11-06 | Ms. Ellen M. ZaneIndependent Director | -12.89k | 1.27M | Automatic Disposition | 98.28 | 24.13k | -34.82% |
| 2025-11-03 | Mr. Joseph M. FitzgeraldExec. VP & Group President of Cardiovascular | -50.00k | 3.67M | Derivative Exercise and Sale | 26.15 - 100.75 | 183.58k | - |
| 2025-10-30 | Mr. Michael F. MahoneyChairman, President & CEO | -149.99k | 0.00 | Other Disposition | - | 1.69M | -8.15% |
| 2025-10-27 | Ms. Ellen M. ZaneIndependent Director | -12.89k | 1.31M | Automatic Disposition | 101.13 - 102.24 | 24.13k | -34.82% |
| 2025-10-01 | Mr. Joseph M. FitzgeraldExec. VP & Group President of Cardiovascular | -50.00k | 3.62M | Derivative Exercise and Sale | 26.15 - 98.91 | 183.58k | - |
| 2025-09-02 | Mr. Joseph M. FitzgeraldExec. VP & Group President of Cardiovascular | -50.00k | 3.96M | Derivative Exercise and Sale | 26.15 - 105.85 | 183.58k | - |
| 2025-08-01 | Mr. Edward J. LudwigLead Independent Director | -500.00 | 0.00 | Other Disposition | - | 17.98k | -2.71% |
| 2025-08-01 | Mr. Joseph M. FitzgeraldExec. VP & Group President of Cardiovascular | -50.00k | 3.92M | Derivative Exercise and Sale | 26.15 - 104.63 | 183.58k | - |
| 2025-08-02 | Mr. Jonathan R. MonsonExec. VP & CFO | 562.00 | 0.00 | Derivative Exercise and Retained Stock | - | 35.29k | 1.62% |
| 2025-08-02 | Mr. Jonathan R. MonsonExec. VP & CFO | -528.00 | 55.66k | Derivative Exercise and Sale | 105.41 | 35.29k | - |
| 2025-08-01 | Mr. Arthur Crosswell ButcherExec. VP and Group President of MedSurg & Asia Pacific | -17.31k | 1.38M | Derivative Exercise and Sale | 17.26 - 104.63 | 36.96k | - |
| 2025-07-29 | Mr. Yoshiaki Fujimoriインサイダー | -2.90k | 310.38k | 売り | 106.99 | 2.08k | -58.23% |
| 2025-07-25 | Mr. Edward J. LudwigLead Independent Director | -4.00k | 424.12k | 売り | 106.03 | 18.48k | -17.79% |
| 2025-07-01 | Mr. Vance R. BrownEVP, General Counsel & Corporate Secretary | 2.08k | 0.00 | Derivative Exercise and Retained Stock | - | 33.45k | 6.64% |
| 2025-07-01 | Mr. Vance R. BrownEVP, General Counsel & Corporate Secretary | -1.95k | 204.53k | Derivative Exercise and Sale | 104.78 | 33.45k | - |
| 2025-07-01 | Mr. Joseph M. FitzgeraldExec. VP & Group President of Cardiovascular | -50.00k | 4.04M | Derivative Exercise and Sale | 26.15 - 106.97 | 183.58k | - |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。